Sponsor content
842 result(s) found, displaying 291 to 300
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial.
-
Prescription medicine registrationActive ingredients: Cinacalcet hydrochloride.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., 29/01/2023
-
Prescription medicine registrationActive ingredients: Rivaroxaban.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO CIPHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.